Sigma Healthcare Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
29 Nov 24 | SellUS$35,289,440 | HMC Capital Limited | Company | 20,000,000 | US$1.89 | |
11 Nov 24 | BuyUS$18,978,414 | Perpetual Limited | Company | 14,418,205 | US$1.67 | |
11 Nov 24 | SellUS$41,014,708 | Perpetual Limited | Company | 26,810,819 | US$1.53 | |
08 Nov 24 | SellUS$61,397,310 | HMC Capital Limited | Company | 40,200,000 | US$1.74 | |
31 Oct 24 | BuyUS$22,271,403 | Challenger Limited | Company | 22,569,409 | US$0.99 | |
31 Oct 24 | SellUS$8,623,076 | Challenger Limited | Company | 6,609,266 | US$1.30 | |
22 Oct 24 | BuyUS$148,847 | State Street Global Advisors, Inc. | Company | 119,742 | US$1.24 | |
22 Oct 24 | SellUS$70,835 | State Street Global Advisors, Inc. | Company | 57,292 | US$1.24 | |
16 Oct 24 | BuyUS$19,590 | State Street Global Advisors, Inc. | Company | 261,964 | US$1.26 | |
11 Oct 24 | BuyUS$1,249,747 | HMC Capital Limited | Company | 1,000,000 | US$1.25 | |
04 Oct 24 | SellUS$2,158 | State Street Global Advisors, Inc. | Company | 417,676 | US$1.38 | |
03 Oct 24 | SellUS$28,970,160 | Perpetual Limited | Company | 25,973,535 | US$1.20 | |
03 Oct 24 | SellUS$33,937,512 | HMC Capital Limited | Company | 26,000,000 | US$1.40 | |
02 Oct 24 | BuyUS$9,026,341 | Perpetual Limited | Company | 8,622,905 | US$1.05 | |
02 Oct 24 | BuyUS$330,403 | State Street Global Advisors, Inc. | Company | 2,469,850 | US$1.30 | |
30 Aug 24 | BuyUS$12,391,512 | Challenger Limited | Company | 14,725,540 | US$0.84 | |
28 Aug 24 | SellUS$1,839 | State Street Global Advisors, Inc. | Company | 10,186,124 | US$0.90 | |
15 Aug 24 | BuyUS$0 | State Street Global Advisors, Inc. | Company | 32,447,188 | US$0.91 | |
05 Aug 24 | BuyUS$21,170,918 | Cooper Investors Pty Limited | Company | 26,133,129 | US$0.81 | |
23 Jul 24 | SellUS$39,128,925 | HMC Capital Limited | Company | 45,610,978 | US$0.86 | |
26 Jun 24 | SellUS$469,846 | Challenger Limited | Company | 551,300 | US$0.85 | |
18 Jun 24 | BuyUS$13,215,923 | Perpetual Limited | Company | 17,271,810 | US$0.77 | |
11 Jun 24 | BuyUS$57,417,513 | Challenger Limited | Company | 89,684,175 | US$0.64 | |
06 Jun 24 | BuyUS$6,937,231 | Perpetual Limited | Company | 8,469,488 | US$0.82 | |
03 Jun 24 | SellUS$4,958,935 | Perpetual Limited | Company | 5,906,553 | US$0.84 | |
16 May 24 | SellUS$933,141 | Challenger Limited | Company | 1,167,800 | US$0.80 | |
03 May 24 | BuyUS$63,623,309 | Cooper Investors Pty Limited | Company | 76,400,443 | US$0.83 | |
30 Apr 24 | SellUS$3,772,895 | Cooper Investors Pty Limited | Company | 4,648,873 | US$0.81 | |
08 Apr 24 | SellUS$7,814,756 | Perpetual Limited | Company | 10,031,418 | US$0.78 | |
02 Apr 24 | SellUS$54,235,249 | HMC Capital Limited | Company | 65,966,599 | US$0.85 | |
28 Mar 24 | BuyUS$4,651,885 | Perpetual Limited | Company | 6,706,067 | US$0.69 | |
20 Mar 24 | BuyUS$8,281,323 | The Vanguard Group, Inc. | Company | 10,066,311 | US$0.82 | |
20 Mar 24 | SellUS$500,811 | The Vanguard Group, Inc. | Company | 628,517 | US$0.80 | |
30 Jan 24 | SellUS$18,042,984 | HMC Capital Limited | Company | 28,365,150 | US$0.64 | |
29 Jan 24 | BuyUS$50,395,781 | HMC Capital Limited | Company | 109,207,767 | US$0.46 | |
29 Jan 24 | BuyUS$111,342 | Kathryn Spargo | Individual | 241,278 | US$0.46 | |
29 Jan 24 | BuyUS$2,988 | Neville Mitchell | Individual | 6,474 | US$0.46 | |
29 Jan 24 | BuyUS$37,584 | Michael Sammells | Individual | 81,444 | US$0.46 | |
29 Jan 24 | BuyUS$1,711 | Annette Carey | Individual | 3,708 | US$0.46 | |
27 Jan 24 | BuyUS$41,663,588 | Perpetual Limited | Company | 77,227,873 | US$0.54 | |
24 Jan 24 | SellUS$429,819 | Perpetual Limited | Company | 652,976 | US$0.66 | |
22 Jan 24 | BuyUS$120,856 | The Vanguard Group, Inc. | Company | 192,831 | US$0.64 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 4,913,777 | 0.313% |
Individual Insiders | 19,647,698 | 1.25% |
Employee Share Scheme | 37,184,497 | 2.37% |
Public Companies | 114,464,558 | 7.28% |
General Public | 616,873,192 | 39.2% |
Institutions | 778,616,768 | 49.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 25.9%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
121,157,064 | US$217.1m | 16.5% | 6.5% | |||
119,834,772 | US$214.7m | 0% | 11.95% | |||
114,464,558 | US$205.1m | -42.7% | no data | |||
103,627,067 | US$185.7m | 29.7% | 0.01% | |||
88,799,405 | US$159.1m | -12.3% | 0.43% | |||
81,637,483 | US$146.3m | 0% | no data | |||
70,995,692 | US$127.2m | 0% | 5.91% | |||
52,841,097 | US$94.7m | 0% | 0.01% | |||
41,837,704 | US$75.0m | 0% | 0.21% | |||
37,184,497 | US$66.6m | 0% | 100.0% | |||
22,762,335 | US$40.8m | 9.42% | no data | |||
17,890,219 | US$32.1m | 0% | no data | |||
17,750,912 | US$31.8m | 52.2% | no data | |||
17,138,910 | US$30.7m | 0% | 0.95% | |||
8,003,091 | US$14.3m | 2.73% | 0.08% | |||
7,928,301 | US$14.2m | 0% | no data | |||
5,915,171 | US$10.6m | 1.78% | no data | |||
5,204,137 | US$9.3m | 205% | 0.16% | |||
4,906,459 | US$8.8m | 0% | no data | |||
3,315,488 | US$5.9m | 0% | 0.06% | |||
2,026,923 | US$3.6m | -7.91% | no data | |||
1,453,022 | US$2.6m | -33.8% | no data | |||
1,032,681 | US$1.9m | -0.27% | no data | |||
953,625 | US$1.7m | 0% | no data | |||
719,679 | US$1.3m | 0% | no data |
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/07 11:47 |
End of Day Share Price | 2024/11/29 00:00 |
Earnings | 2024/07/31 |
Annual Earnings | 2024/01/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sigma Healthcare Limited is covered by 24 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
John Hester | ANZ Equities Pty Limited |
Dennis Hulme | APP Securities Pty Ltd. |
Russell Wright | Barclay Pearce Capital Pty Limited |